nifedipine has been researched along with apomorphine in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (15.79) | 18.7374 |
1990's | 4 (21.05) | 18.2507 |
2000's | 6 (31.58) | 29.6817 |
2010's | 6 (31.58) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bourson, A; Moser, PC | 1 |
Freed, WJ; Grebb, JA; Shelton, RC | 1 |
Poiletman, RM; Shah, AB; Shah, NS | 1 |
Antkiewicz-Michaluk, L; Michaluk, J; Romańska, I; Vetulani, J | 1 |
Chang, YH; Conceição, IM; Frussa-Filho, R; Maiolini Júnior, M; Mattia, NF; Smaili, S | 1 |
Antkiewicz-Michaluk, L; Michaluk, J; Vetulani, J | 1 |
Antkiewicz-Michaluk, L; Karolewicz, B; Michaluk, J; Vetulani, J | 1 |
Armando, I; Belforte, JE; Buño, W; Magariños-Azcone, C; Pazo, JH | 1 |
Adams, MA; Hale, TM; Hannan, JL; Heaton, JP; Smallegange, C | 1 |
Ma, Z; Wang, J; Wang, R; Xie, J | 1 |
Chen, KX; Ding, H; Du, DH; Hu, JC; Jiang, HL; Kong, XQ; Li, LC; Liu, JQ; Luo, C; Zhu, MR | 1 |
1 review(s) available for nifedipine and apomorphine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
18 other study(ies) available for nifedipine and apomorphine
Article | Year |
---|---|
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The effect of pre- and postoperative procedures on physostigmine- and apomorphine-induced yawning in rats.
Topics: Animals; Apomorphine; Desipramine; Drug Interactions; Male; Medial Forebrain Bundle; Nifedipine; Pentobarbital; Physostigmine; Rats; Rats, Inbred Strains; Stress, Physiological; Surgical Procedures, Operative; Yawning | 1989 |
Diltiazem or verapamil prevents haloperidol-induced apomorphine supersensitivity in mice.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Diltiazem; Drug Hypersensitivity; Haloperidol; Mice; Mice, Inbred Strains; Nifedipine; Verapamil | 1987 |
The influence of nisoldipine--a "calcium entry blocker" on drug induced stereotyped behavior in rats.
Topics: Age Factors; Animals; Apomorphine; Arousal; Calcium Channel Blockers; Humans; Motor Activity; Nifedipine; Nisoldipine; Phencyclidine; Pyridines; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1983 |
Differential involvement of voltage-dependent calcium channels in apomorphine-induced hypermotility and stereotypy.
Topics: Animals; Apomorphine; Calcium Channel Blockers; Calcium Channels; Electrophysiology; Electroshock; Male; Morphine; Motor Activity; Nifedipine; Rats; Rats, Wistar; Stereotyped Behavior; Substance Withdrawal Syndrome; Up-Regulation | 1994 |
Effects of single and long-term administration of nifedipine on dopamine-related behaviors.
Topics: Animals; Apomorphine; Behavior, Animal; Injections, Intraperitoneal; Male; Nifedipine; Random Allocation; Rats; Rats, Wistar; Receptors, Dopamine; Stereotyped Behavior; Time Factors | 1994 |
Modification of effects of chronic electroconvulsive shock by voltage-dependent Ca2+ channel blockade with nifedipine.
Topics: Animals; Apomorphine; Behavior, Animal; Calcium Channel Blockers; Calcium Channels; Cerebral Cortex; Electroshock; Hippocampus; Hyperalgesia; Male; Membranes; Motor Activity; Nifedipine; Nitrendipine; Rats; Rats, Wistar; Seizures; Up-Regulation; Weight Gain | 1994 |
Differences between haloperidol- and pimozide-induced withdrawal syndrome: a role for Ca2+ channels.
Topics: Animals; Antipsychotic Agents; Apomorphine; Calcium Channels; Haloperidol; Male; Motor Activity; Nifedipine; Nitrendipine; Pimozide; Rats; Rats, Wistar; Receptors, Dopamine D1; Substance Withdrawal Syndrome | 1995 |
Pharmacological involvement of the calcium channel blocker flunarizine in dopamine transmission at the striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Calcium Channel Blockers; Calcium Channels, L-Type; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Flunarizine; Haloperidol; Male; Microinjections; Neostriatum; Nifedipine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Synapses; Synaptic Transmission | 2001 |
Impact of antihypertensive treatments on erectile responses in aging spontaneously hypertensive rats.
Topics: Aging; Animals; Antihypertensive Agents; Apomorphine; Blood Pressure; Enalapril; Hydralazine; Hydrochlorothiazide; Hypertension; Kidney Transplantation; Losartan; Male; Nifedipine; Penile Erection; Random Allocation; Rats; Rats, Inbred SHR; Testosterone | 2006 |
L-type Cav1.2 calcium channel is involved in 6-hydroxydopamine-induced neurotoxicity in rats.
Topics: Animals; Antiparkinson Agents; Apomorphine; Calcium Channel Blockers; Calcium Channels, L-Type; Dopamine; Dopaminergic Neurons; Drug Interactions; Female; Nifedipine; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; RNA, Messenger; Substantia Nigra; Sympatholytics | 2012 |
Development of a high-throughput fluorescence polarization assay for the discovery of EZH2-EED interaction inhibitors.
Topics: Apomorphine; Enhancer of Zeste Homolog 2 Protein; Ergonovine; Fluorescence Polarization; High-Throughput Screening Assays; Humans; Hydrogen-Ion Concentration; Limit of Detection; Nifedipine; Oxyphenbutazone; Peptide Fragments; Polycomb Repressive Complex 2; Protein Binding; Protein Multimerization; Temperature | 2018 |